Vor Biopharma

Overview

Develops telitacicept, a BAFF/APRIL inhibitor for autoimmune diseases, aiming to rebalance immunity by blocking survival signals for harmful immune cells.

Part of the Boston ecosystem

Related

• AsimovBuilds an end-to-end genetic design platform combining synthetic biology and computational tools for biologics, cell therapy, and gene therapy development.
• Atlas VentureBuilds biotechnology companies by partnering with life science entrepreneurs to translate scientific research into medicines for patients with medical needs.
• Beam Therapeutics ($BEAM)Develops investigational base-editing genetic medicines and delivery technologies, including electroporation, nonviral, and viral methods, for patients suffering from serious diseases worldwide.
• Flagship PioneeringBuilds life sciences companies through scientific exploration and strategic collaborations, aiming to create products for drug discovery, health, and sustainability needs.
• Ginkgo Bioworks ($DNA)Builds autonomous labs and services that let scientists order robotic experiments, helping biotechnology teams reduce manual benchwork across biopharma, agriculture, and industrial biotech.
• LabCentralProvides shared laboratory space, startup resources, pathway programs, workshops, events, and media for early-stage life science startups and people entering biotech careers.
• Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial focused on optic neuropathies.
• Material ImpactBuilds and backs inception-stage deep tech companies using materials science, supporting founders developing products aimed at urgent human needs and cleaner, healthier industries.
• Moderna ($MRNA)Develops mRNA medicines using a platform for designing, researching, and testing mRNA, with a focus on addressing infectious and serious diseases.
• Pillar VCInvests at inception in technical founders pursuing breakthrough companies, and provides founder resources such as playlists, startup templates, events, and guides.
• Prime Medicine ($PRME)Develops one-time genetic therapies using prime editing to locate genome targets and replace faulty DNA segments for patients with diseases caused by mutations.
• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about clinical trial opportunities.